BACILLUS CALMETTE-GUÉRIN VACCINATION
Showing 1 - 25 of 3,965
Respiratory Tract Infections, Covid19 Trial in Netherlands (Bacille Calmette-Guérin (BCG), Placebo)
Completed
- Respiratory Tract Infections
- Covid19
- Bacille Calmette-Guérin (BCG)
- Placebo
-
Amersfoort, Netherlands
- +19 more
Sep 21, 2022
COVID-19 Trial in Netherlands (BCG Vaccine, Placebo)
Completed
- COVID-19
- BCG Vaccine
- Placebo
-
Den Bosch, Brabant, Netherlands
- +8 more
Jun 2, 2022
Coronavirus, Coronavirus Infection, Coronavirus as the Cause of Diseases Classified Elsewhere Trial in Los Angeles, Bryan,
Active, not recruiting
- Coronavirus
- +2 more
- BCG Vaccine
- Placebo Vaccine
-
Los Angeles, California
- +5 more
Oct 18, 2022
Infection, Hospitalization, Mortality Trial in Athens (Vaccination, Placebo)
Completed
- Infection
- +2 more
- Vaccination
- Placebo
-
Athens, Attiki, Greece4th Department of Internal Medicine, ATTIKON University Hospital
Jan 8, 2021
HIV-1-infection Trial in Zurich (BCG Vaccine AJVaccines)
Recruiting
- HIV-1-infection
- BCG Vaccine AJVaccines
-
Zurich, SwitzerlandUniversity Hospital Zurich
Jan 28, 2022
COVID-19, Virus Diseases, Corona Virus Infection Trial in Greece (BCG vaccine, Placebo)
Completed
- COVID-19
- +4 more
- BCG vaccine
- Placebo
-
Náfplio, Argos, Greece
- +14 more
May 9, 2021
Mild Cognitive Impairment, Healthy Trial in Charlestown (Bacillus Calmette-Guerin (BCG))
Active, not recruiting
- Mild Cognitive Impairment
- Healthy
- Bacillus Calmette-Guerin (BCG)
-
Charlestown, MassachusettsClinical Translational Research Unit
Jul 18, 2022
Tuberculosis Trial (Intradermal BCG (bacillus calmette-guerin) vaccine AJV)
Not yet recruiting
- Tuberculosis
- Intradermal BCG (bacillus calmette-guerin) vaccine AJV
- (no location specified)
Apr 17, 2023
Mild Cognitive Impairment, Mild Dementia, Moderate Dementia Trial in Charlestown (Biological/Vaccine: Bacillus Calmette-Guerin
Active, not recruiting
- Mild Cognitive Impairment
- +3 more
- Biological/Vaccine: Bacillus Calmette-Guerin (BCG)
-
Charlestown, MassachusettsAlzheimer's Clinical and Translational Research Unit
Feb 2, 2023
Diabetes, Type 1 Diabetes, Diabetes type1 Trial in Charlestown (Bacillus Calmette-Guérin, Saline Injection)
Recruiting
- Diabetes Mellitus
- +3 more
- Bacillus Calmette-Guérin
- Saline Injection
-
Charlestown, MassachusettsImmunobiology Labs CNY 149
May 10, 2023
Bladder Cancer, Bacillus Calmette-Guerin Trial in Campinas (Bacillus Calmette Guerin, PLACEBO)
Active, not recruiting
- Bladder Cancer
- Bacillus Calmette-Guerin
- Bacillus Calmette Guerin
- PLACEBO
-
Campinas, SP, BrazilHospital das Clínicas Unicamp
May 18, 2022
Diabetes, Type One, Diabetes, Type I, Autoimmune Diabetes Trial in Charlestown (Bacillus Calmette-Guérin, Saline injection)
Active, not recruiting
- Diabetes Mellitus, Type One
- +3 more
- Bacillus Calmette-Guérin
- Saline injection
-
Charlestown, MassachusettsImmunobiology Labs CNY 149
Jun 17, 2022
Bacillus Calmette Guerin With Use of Different Types of Urinary
Completed
- Non-muscle-invasive Bladder Cancer
-
Marathon, Attica, GreeceThemistoklis Bellos
Jan 10, 2023
COVID-19 Trial in Brazil (BCG (Bacillus Calmette-Guérin) vaccine, Placebo)
Recruiting
- COVID-19
- BCG (Bacillus Calmette-Guérin) vaccine
- Placebo
-
Manaus, Amazonas, Brazil
- +3 more
Aug 17, 2022
Urinary Bladder Cancer Trial in Tucson (Gemcitabine)
Not yet recruiting
- Urinary Bladder Cancer
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Dec 21, 2022
Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)
Recruiting
- Urinary Bladder Neoplasms
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Bladder Cancer Trial in Switzerland (Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC), Atezolizumab, Cisplatin)
Recruiting
- Bladder Cancer
- Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC)
- +3 more
-
Baden, Switzerland
- +9 more
Aug 12, 2022
COVID-19, Therapeutic Vaccine, BCG Trial in Campinas (BCG, Placebo)
Active, not recruiting
- COVID-19
- +4 more
- BCG
- Placebo
-
Campinas, SP, BrazilHospital das Clínicas Unicamp
Mar 23, 2022
Diabetes, Type 1, Diabetes type1, Autoimmune Diabetes Trial in Charlestown (Bacillus Calmette-Guérin, Saline Injection)
Recruiting
- Diabetes Mellitus, Type 1
- +2 more
- Bacillus Calmette-Guérin
- Saline Injection
-
Charlestown, MassachusettsImmunobiology Labs CNY 149
Mar 22, 2022
Bladder Cancer, High Risk Superficial Trial in United States (Bacillus Calmette-Guérin (BCG))
Completed
- Bladder Cancer
- High Risk Superficial
- Bacillus Calmette-Guérin (BCG)
-
Basking Ridge, New Jersey
- +4 more
Feb 28, 2022
Fibromyalgia Trial in Charlestown (Bacillus Calmette Guerin Vaccine, Saline Injection)
Withdrawn
- Fibromyalgia
- Bacillus Calmette Guerin Vaccine
- Saline Injection
-
Charlestown, MassachusettsImmunobiology Labs CNY 149
Apr 5, 2022
Bladder Cancer Trial (pembrolizumab)
Active, not recruiting
- Bladder Cancer
- Pembrolizumab
- +2 more
- (no location specified)
Oct 11, 2022
Alzheimer, Late Onset Trial in Eau Claire (Bacillus of Calmette and Guerin (BCG))
Completed
- Alzheimer Disease, Late Onset
- Bacillus of Calmette and Guerin (BCG)
-
Eau Claire, WisconsinMindful Diagnostics and Therapeutics
Dec 22, 2021
Recurrent Bladder Carcinoma, Stage 0a Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma Trial in Chicago (BCG
Active, not recruiting
- Recurrent Bladder Carcinoma
- +3 more
- BCG Solution
- +3 more
-
Chicago, IllinoisNorthwestern University
Sep 27, 2022
Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)
Not yet recruiting
- Non-Muscle- Invasive Bladder Cancer
- Durvalumab
- BCG
- (no location specified)
Jul 5, 2023